Medytox, 31,110 Shares Net Sold by Foreigners in Last 5 Days... Stock Price at 235,100 Won (-3.29%)

Medytox is trading at 235,100 KRW as of 1:30 PM on the 19th, down 3.29% from the previous day. The trading volume is 1,401,360 shares, which is 871.29% of the previous day's volume. Medytox is known as a manufacturer and seller of pharmaceuticals and aesthetic pharmaceuticals.

On August 18, Hana Financial Investment researcher Minjeong Seon stated, "Medytox is currently involved in litigation, and with this recent ruling, Medytox can produce and sell Meditoxin during the period when the main lawsuit is ongoing. According to the clinical development schedule, once the Phase 3 clinical trial of Innotox is completed by the end of this year, it is expected that the BLA can be submitted in the first half of 2021. With the ITC preliminary ruling victory, the ability to produce and sell Meditoxin, and the expected completion of Innotox’s Phase 3 trial, only positive factors remain for Medytox." She set Medytox’s target price at 400,000 KRW.

Over the past five days, individual investors have net purchased 19,297 shares of Medytox, while foreigners and institutions have net sold 30,110 shares and net purchased 4,738 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.